Literature DB >> 9349468

In vivo induction of interferon-alpha in pig by non-infectious coronavirus: tissue localization and in situ phenotypic characterization of interferon-alpha-producing cells.

S Riffault1, C Carrat, L Besnardeau, C La Bonnardière, B Charley.   

Abstract

A low frequency peripheral blood mononuclear cell (PBMC) subpopulation, referred to as natural interferon-producing (NIP) cells, is described as producing interferon-alpha (IFN-alpha) following contact with non-infectious viral structures, namely viral glycoproteins. These cells are characterized in vitro as non-T, non-B, MHC class II+ and CD4+ cells. In this study, NIP cells were analysed in vivo after an intravenous injection of UV-inactivated transmissible gastroenteritis virus in newborn piglets, which resulted in strong serum IFN-alpha production. Splenocytes, but not PBMC, were the IFN-alpha producers in vivo. Using double immunohistochemical labelling for both IFN-alpha and leukocyte markers, we established that splenic NIP cells were not T or B cells. The majority were MHC class II+ and only a minority expressed a macrophage marker. NIP cells were localized in contact with MHC class II-expressing cells and T cells, which suggested that NIP cells might modulate the antiviral immune response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349468     DOI: 10.1099/0022-1317-78-10-2483

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Porcine peripheral blood dendritic cells and natural interferon-producing cells.

Authors:  Artur Summerfield; Laurence Guzylack-Piriou; Alexander Schaub; Carlos P Carrasco; Valerie Tâche; Bernard Charley; Kenneth C McCullough
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

2.  Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.

Authors:  Patrizia Carotenuto; Debby van Riel; André Artsen; Sven Bruijns; Fons G Uytdehaag; Jon D Laman; Andeltje B van Nunen; Pieter E Zondervan; Robert A De Man; Albert D Osterhaus; Oscar Pontesilli
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes.

Authors:  P Baudoux; C Carrat; L Besnardeau; B Charley; H Laude
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 4.  Porcine innate and adaptative immune responses to influenza and coronavirus infections.

Authors:  Bernard Charley; Sabine Riffault; Kristien Van Reeth
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

Review 5.  Modulation of Innate Antiviral Immune Response by Porcine Enteric Coronavirus.

Authors:  Kunli Zhang; Sen Lin; Jianhao Li; Shoulong Deng; Jianfeng Zhang; Sutian Wang
Journal:  Front Microbiol       Date:  2022-02-14       Impact factor: 5.640

6.  Characterization of the cytokine and maturation responses of pure populations of porcine plasmacytoid dendritic cells to porcine viruses and toll-like receptor agonists.

Authors:  Gabriela Calzada-Nova; William Schnitzlein; Robert Husmann; Federico A Zuckermann
Journal:  Vet Immunol Immunopathol       Date:  2009-10-30       Impact factor: 2.046

Review 7.  The porcine dendritic cell family.

Authors:  Artur Summerfield; Kenneth C McCullough
Journal:  Dev Comp Immunol       Date:  2008-06-06       Impact factor: 3.636

Review 8.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

9.  [Why domestic animals are useful in immunology].

Authors:  Bernard Charley
Journal:  Bull Acad Natl Med       Date:  2008 Jun-Jul       Impact factor: 0.144

10.  Characteristics of oligodeoxyribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells.

Authors:  Kristina Domeika; Mattias Magnusson; Maija-Leena Eloranta; Lisbeth Fuxler; Gunnar V Alm; Caroline Fossum
Journal:  Vet Immunol Immunopathol       Date:  2004-09       Impact factor: 2.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.